Acute kidney injury: Acute kidney injury: still misunderstood and misdiagnosed
- PMID: 28163310
- PMCID: PMC6069532
- DOI: 10.1038/nrneph.2017.9
Acute kidney injury: Acute kidney injury: still misunderstood and misdiagnosed
Abstract
New research supports the notion that pre-renal and intrinsic acute kidney injury are distinct molecular entities and hence different disease states despite similar increases in serum creatinine level. Pre-renal AKI induces protective molecular mechanisms whereas intrinsic AKI requires a ‘second hit’ that upregulates injury genes, and results in a persistent elevation of serum creatinine and kidney injury biomarkers.
Conflict of interest statement
P.D. is a co-inventor on patents (7776824 and 7977110) related to NGAL as a biomarker of kidney injury, and declares licensing agreements with BioPorto Diagnostics and Abbott Diagnostics.
Comment on
-
Unique Transcriptional Programs Identify Subtypes of AKI.J Am Soc Nephrol. 2017 Jun;28(6):1729-1740. doi: 10.1681/ASN.2016090974. Epub 2016 Dec 27. J Am Soc Nephrol. 2017. PMID: 28028135 Free PMC article.
References
-
- KDIGO. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
-
- Uchino S, Bellomo R, Bagshaw SM, Goldsmith D. Transient azotemia is associated with a high risk of death in hospitalized patients. Nephrol Dial Transplant. 2010;25:1833–1839. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
